Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily G member 8 | 0.573 | 0.538 | 2.4E-20 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
prostaglandin F receptor | 0.705 | 0.423 | 6.6E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
tripartite motif containing 54 | 0.861 | 0.231 | 5.5E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
decaprenyl diphosphate synthase subunit 2 | 0.626 | 0.577 | 4.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
carboxypeptidase A6 | 0.716 | 0.346 | 4.4E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
proteasome 26S subunit, non-ATPase 1 | 0.780 | 0.231 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
pyridoxal phosphatase | 0.533 | 0.731 | 0.26 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ADP-ribose/CDP-alcohol diphosphatase, manganese dependent | 4.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||||
|
formin 2 | 0.610 | 0.538 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2012 | 2012 | ||||||||
|
protein kinase, DNA-activated, catalytic subunit | 0.540 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
hemogen | 0.729 | 0.500 | 1.0E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
F-box and leucine rich repeat protein 8 | 3.9E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||||
|
macoilin 1 | 1.000 | 0.038 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
Ral GEF with PH domain and SH3 binding motif 2 | 0.805 | 0.154 | 0.26 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
basonuclin 2 | 0.612 | 0.615 | 0.93 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
peroxisome proliferator activated receptor delta | 0.513 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
UDP glucuronosyltransferase family 1 member A3 | 0.623 | 0.538 | 1.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
transmembrane and immunoglobulin domain containing 3 | 0.839 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
DS cell adhesion molecule like 1 | 0.839 | 0.346 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2018 | ||||||||
|
ribokinase | 0.890 | 0.077 | 5.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 5 | 2012 | 2012 | ||||||||
|
SEC13 homolog, nuclear pore and COPII coat complex component | 1.000 | 0.115 | 1.8E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
PDX1 C-terminal inhibiting factor 1 | 0.890 | 0.077 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
BCL2 interacting killer | 0.653 | 0.462 | 5.0E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2008 | 2008 | ||||||||
|
ryanodine receptor 2 | 0.539 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2019 |